Skip to main content
Caplight Logo









Medsensio

Medsensio

Private
OsloHealthcare & Life Scienceshttps://www.medsens.io/

Last Round

Grant

Apr 14, 2023

Total Funding Raised

$954,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medsensio is a healthtech company that provides a platform to improve respiratory diagnostics and remote patient monitoring using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Telemedicine, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Data as a Service

AI Layer

Application

Keywords

remote patient monitoringauscultation analysismedical AIchronic disease managementhospital at homeclinical decision supportdigital healthlung sound analysisheart sound analysiscardiac monitoringpulmonary monitoringtelemedicinevirtual careCOPD monitoringheart failure monitoringhealthcare SaaSmHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medsensio Comparables

Compare Medsensio with similar companies based on industry and business-model similarity.

Medsensio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sonavi Labs, Inc.
83%
eMurmur
82%
Strados Labs
76%

Medsensio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 14, 2023
GrantSep 8, 2020
Pre SeedSep 1, 2020

Key People

Founding team and executive leadership

Johan Ravn

Co-founder And CTO At Medsensio

Founding Team

Anna Dranovska

Co-founder And CEO

Founding Team

Medsensio Investors

Notable investors and investment history

Medsensio investors
InvestorRounds
European Innovation Council FundGrant
InvestinorPre Seed
NorinnovaPre Seed
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 40% MoM.

  • Jan 19, 2026

    Monthly visitors grew 61% MoM, from 654 to 1.1K.

Medsensio Filings

Explore SEC and related filing metadata, where available.

Medsensio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medsensio's valuation, stock price, and market status.

Is Medsensio a public or private company?

Medsensio is a private company.

What is the current stock price of Medsensio?

Medsensio is a private company with no public stock price. No recent secondary market data is available.

How much is Medsensio worth (valuation)?

Valuation information for Medsensio is not publicly available.

Can I buy Medsensio stock?

Medsensio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medsensio's last funding round?

Medsensio's most recent funding round was Grant on April 14, 2023.

Who are the main investors in Medsensio?

Key investors in Medsensio include European Innovation Council, European Union.

Will Medsensio IPO soon?

No public IPO plans have been announced for Medsensio.

How can I track Medsensio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medsensio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range7
Year Founded2017
Last FundingApr 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?